1. Home
  2. EPR vs HAE Comparison

EPR vs HAE Comparison

Compare EPR & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EPR Properties

EPR

EPR Properties

HOLD

Current Price

$54.97

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$70.06

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EPR
HAE
Founded
1997
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.9B
IPO Year
1997
1991

Fundamental Metrics

Financial Performance
Metric
EPR
HAE
Price
$54.97
$70.06
Analyst Decision
Buy
Buy
Analyst Count
11
9
Target Price
$57.06
$88.75
AVG Volume (30 Days)
706.8K
673.3K
Earning Date
02-25-2026
02-05-2026
Dividend Yield
6.45%
N/A
EPS Growth
N/A
42.54
EPS
2.29
3.44
Revenue
$707,150,000.00
$1,327,850,000.00
Revenue This Year
$5.20
N/A
Revenue Next Year
$2.95
$6.01
P/E Ratio
$24.01
$20.38
Revenue Growth
3.73
N/A
52 Week Low
$41.75
$47.32
52 Week High
$61.24
$87.32

Technical Indicators

Market Signals
Indicator
EPR
HAE
Relative Strength Index (RSI) 68.03 27.72
Support Level $54.51 $69.78
Resistance Level $56.03 $73.00
Average True Range (ATR) 1.05 2.65
MACD 0.37 -1.62
Stochastic Oscillator 84.21 2.39

Price Performance

Historical Comparison
EPR
HAE

About EPR EPR Properties

EPR Properties is a real estate investment trust that focuses on underwriting experiential property investments on key industry and property cash flow criteria, and the credit metrics of tenants and customers. The company invests in two property segments: Experiential, including theaters, family entertainment centers, ski resorts, and other attractions; and Education, including early childhood education centers and private school properties. The Company's business is focused on Experiential real estate. The majority of revenue comes from the Experiential sector.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: